Attached files
file | filename |
---|---|
EX-5.1 - EX-5.1 - Verve Therapeutics, Inc. | d156900dex51.htm |
S-1MEF - S-1MEF - Verve Therapeutics, Inc. | d156900ds1mef.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement on Form S-1 filed pursuant to Rule 462(b) of the Securities Act of 1933 of the reference to our firm under the caption Experts and to the incorporation by reference of our report dated April 16, 2021 (except for Note 17(E), as to which the date is June 14, 2021), with respect to the consolidated financial statements of Verve Therapeutics, Inc. included in Amendment No. 1 to the Registration Statement (Form S-1), and related Prospectus of Verve Therapeutics, Inc. for the registration of its common stock.
/s/ Ernst & Young LLP
Boston, Massachusetts
June 16, 2021